| 标题 |
Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase 2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Rheumatology 作者:Ian N Bruce; Alireza Nami; Erik Schwetje; M. Edward Pierson; Tomas Rouse; et al 出版日期:2020-11-20 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)